| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 17,844 | 17,425 | 17,656 | 19,963 | | Cost of Revenue | 3,228 | 3,394 | 4,030 | 4,750 | | | Gross Profit | 14,616 | 14,031 | 13,626 | 15,213 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,096 | 12,240 | 11,202 | 10,242 | | Non Recurring | 166 |
-
|
-
|
-
| | Others | 7,610 | 10,544 | 10,580 | 4,676 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,256) | (8,753) | (8,156) | 295 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (3,256) | (8,753) | (8,156) | 295 | | Interest Expense | 644 | 741 | 851 | 1,021 | | Income Before Tax | (3,900) | (9,494) | (9,007) | (726) | | Income Tax Expense | (1,825) | (4,113) | (5,052) | (1,426) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,075) | (5,381) | (3,955) | 700 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,075) | (5,381) | (3,955) | 700 | | Preferred Stock And Other Adjustments | (600) | (591) | (585) | (255) | | | Net Income Applicable To Common Shares | ($2,675) | ($5,972) | ($4,540) | $445 |
|
0.51% Nasdaq 
Income Statement
